Logo Image

Authors

Zahiah (Zee Zee) Gueddar

Senior Director, Commercialization, IQVIA Technologies

Latest Article

Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, and eCOA.

Beth Harper, MBA

Project Manager, Senior Research Consultant with Tufts Center for the Study of Drug Development (Tufts CSDD)

Latest Article

Benchmarking the Investigative Site Qualification Process

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.

Mandis Beigi

Senior Director, Medidata Solutions

Latest Article

Accelerating Breakthroughs with Synthetic Clinical Trial Data

The emergence of AI-powered simulants in improving study efficiency.

Asad Khan

Senior Director, Customer Success, Medable

Latest Article

A Shot in the Arm to Traditional Vaccine Trial Strategy

From planning one Phase III trial at a time to digital standardization on repeat.

Melissa Mooney

Director Solution Engineering, IQVIA Patient Suite, IQVIA Technologies

Latest Article

Beyond the Buzzwords: What SCOPE 2026 Revealed About Clinical Trial Planning and Operations

Insights from SCOPE 2026 highlight the industry’s shift toward connected, data-centric clinical trial ecosystems, where digital protocols, shared data, and renewed scientific rigor are driving more efficient, interoperable, and patient-focused research.